Holen Sie sich die Stockscreener-App
307.21
2.31%
-7.28
Handel nachbörslich:
307.21
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$314.49
Offen:
$312.92
24-Stunden-Volumen:
512.62K
Relative Volume:
0.93
Marktkapitalisierung:
$22.29B
Einnahmen:
$2.88B
Nettoeinkommen (Verlust:
$499.60M
KGV:
41.46
EPS:
7.41
Netto-Cashflow:
$321.60M
1W Leistung:
-6.22%
1M Leistung:
+4.74%
6M Leistung:
-13.62%
1J Leistung:
-10.37%
1-Tages-Spanne:
$305.36
$314.05
1-Wochen-Bereich:
$305.36
$347.53
52-Wochen-Spanne:
$265.00
$413.70
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Vergleichen Sie WST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades' - Benzinga
KBC Group NV Sells 7,441 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Zacks Research Issues Negative Forecast for WST Earnings - MarketBeat
West Pharmaceutical Services (NYSE:WST) Expands AI Solutions to Address Profit Challenges and Competition - Yahoo Finance
Mizuho Securities USA LLC Purchases 15,559 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by ING Groep NV - MarketBeat
UBS: West Pharmaceutical Services, Inc. (NYSE:WST) Is A Bottom-Ranked Quant Stock - Insider Monkey
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Stock Drops Amid Sector Downt - GuruFocus.com
Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now? - Simply Wall St
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Sivik Global Healthcare LLC - MarketBeat
Curi RMB Capital LLC Acquires 2,614 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
US pharma company creates 330 jobs in Dublin - Irish Independent
West continues its investment in Ireland with Dublin manufacturing facility expansion - IDA Ireland
Atria Investments Inc Grows Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Chartwell Investment Partners LLC Has $870,000 Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Principal Financial Group Inc. - MarketBeat
UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors - Insider Monkey
West Pharmaceutical Services To Present At UBS Global Healthcare Conference; Webcast At 6:30 PM ET - Nasdaq
North Growth Management Ltd. Has $5.56 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock rises Friday, still underperforms market - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Forte Capital LLC ADV - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by National Pension Service - MarketBeat
Asset Management One Co. Ltd. Buys 12,745 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock rises Wednesday, still underperforms market - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Pittenger & Anderson Inc. - MarketBeat
West Pharmaceutical Services Inc (WST) Shares Up 3.59% on Nov 5 - GuruFocus.com
Get Ready: West Pharmaceutical Services to Unveil Q3 Financial Results and Insights! - MSN
New York State Common Retirement Fund Decreases Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by New York State Teachers Retirement System - MarketBeat
WST (West Pharmaceutical Services) Revenue : $2,876 Mil (TTM As of Sep. 2024) - GuruFocus.com
International Assets Investment Management LLC Grows Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical's VP Charles Witherspoon sells $218,211 in stock - Investing.com India
West Pharmaceutical Services, Inc. (NYSE:WST) VP Sells $218,211.20 in Stock - MarketBeat
West Pharmaceutical's VP Charles Witherspoon sells $218,211 in stock By Investing.com - Investing.com UK
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Congress Asset Management Co. - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
West Pharmaceutical Services: Expanding Capacity in High-Value Product Lines & Unlocking Commercial Manufacturing Potential!Major Drivers - Smartkarma
West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance - Insider Monkey
AMI Asset Management Corp Has $55.27 Million Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Reports Solid Third-Quarter 2024 Results and Raises Guidance - MSN
West to Participate in Upcoming November 2024 Investor Conferences - BioSpace
West to Participate in Upcoming Investor Conferences - Marketscreener.com
West to Participate in Upcoming Investor Conferences – Company Announcement - Financial Times
On Body Drug Delivery Devices Market: Anticipated Positive - openPR
Buy These 4 Stocks With New Dividend Hikes Amid Market Volatility - MSN
Assenagon Asset Management S.A. Acquires 12,769 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
William Blair Has Negative Estimate for WST Q4 Earnings - MarketBeat
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):